Synapse - Gynecologic Medicine Service

Results (2180)

Outcomes based on treatment regimen in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum-based chemotherapy in combination with veliparib and bevacizumab

Meeting Abstract

Washington, C. R.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer

Meeting Abstract

Friedman, C. F.; Snyder, A.; Abu-Rustum, N. R.; Broach, V.; Brown, C. L.; Bykov, Y.; Cadoo, K. A.; Chi, D. S.; Cohen, S.; Eid, K. T.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Characterization and management of adverse reactions in patients with endometrial carcinoma receiving lenvatinib plus pembrolizumab (Study 111/KEYNOTE-146): Nurse roles in patient education and adverse-reaction management

Meeting Abstract

Soldan, K.; Johns, C.; Taylor, M. H.; Gillis, K.; Orlowski, R.; Min, R.; Makker, V.
Journal of Oncology Navigation & Survivorship (2020)

Fulltext@MSK | Save

Patient-centered outcomes in ARIEL3, a phase III, randomized, placebo-controlled trial of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma

Journal Article

Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group

Guidelines

Battisti, N. M. L.; Mislang, A. R.; Cooper, L.; O'Donovan, A.; Audisio, R. A.; Cheung, K. L.; Sarrió, R. G.; Stauder, R.; Soto-Perez-de-Celis, E.; Jaklitsch, M.; more...
Journal of Geriatric Oncology (2020)

Fulltext@MSK | Save

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

Journal Article

Voss, M. H.; Gordon, M. S.; Mita, M.; Rini, B.; Makker, V.; Macarulla, T.; Smith, D. C.; Cervantes, A.; Puzanov, I.; Pili, R.; more...
British Journal of Cancer (2020)

Fulltext@MSK | Save

MILO/ENGOT-ov11: Binimetinib versus physician’s choice chemotherapy in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum

Journal Article

Monk, B. J.; Grisham, R. N.; Banerjee, S.; Kalbacher, E.; Mirza, M. R.; Romero, I.; Vuylsteke, P.; Coleman, R. L.; Hilpert, F.; Oza, A. M.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients

Journal Article

Machiels, J. P.; Gomez-Roca, C.; Michot, J. M.; Zamarin, D.; Mitchell, T.; Catala, G.; Eberst, L.; Jacob, W.; Jegg, A. M.; Cannarile, M. A.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum

Journal Article

Gershenson, D. M.; Bhosale, P.; Grisham, R. N.
Gynecologic Oncology Reports (2020)

Fulltext@MSK | Save

Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer

Meeting Abstract

Rubinstein, M. M.; Hyman, D.; Caird, I.; O'Cearbhaill, R.; Grisham, R.; Tew, W.; Hensley, M.; Sabbatini, P.; Aghajanian, C.; Iasonos, A.; more...
Molecular Cancer Research (2020)

Fulltext@MSK | Save